Loading
A phase 2 trial of fruquintinib, capecitabine and bevacizumab (glioblastoma use) in colorectal cancer, run by Liu Huang, not yet recruiting.
Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer is a phase 2, randomised interventional study registered as NCT07051785 by Liu Huang, with a registry enrolment figure of 68 participants, started 2025-07-07 and due to reach its primary completion in 2027-07-06. Interventions recorded: Fruquintinib+Irinotecan Liposome+Capecitabine; Bevacizumab+Irinotecan Liposome+Capecitabine. Conditions listed: Colorectal Cancer (CRC). Primary outcome: Progression-free Survival (PFS). Colorectal eligibility wording from the registry: "Patients with metastatic colorectal adenocarcinoma confirmed by pathology or histology;". No results are recorded here; the registry entry is the source.
Shares Fruquintinib, Bevacizumab (glioblastoma use), Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Bevacizumab (glioblastoma use), Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Bevacizumab (glioblastoma use), Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.